Toll-like Receptor Response to Human Immunodeficiency Virus Type 1 or Co-Infection with Hepatitis B or C Virus: An Overview

被引:8
作者
Kayesh, Mohammad Enamul Hoque [1 ]
Kohara, Michinori [2 ]
Tsukiyama-Kohara, Kyoko [3 ]
机构
[1] Patuakhali Sci & Technol Univ, Fac Anim Sci & Vet Med, Dept Microbiol & Publ Hlth, Barishal 8210, Bangladesh
[2] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Tokyo 1568506, Japan
[3] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima 8900065, Japan
关键词
toll-like receptor; TLR agonist; HIV-1; co-infection; HBV; HCV; PLASMACYTOID DENDRITIC CELLS; NF-KAPPA-B; I INTERFERON RESPONSE; SINGLE-STRANDED RNA; HIV-1; INFECTION; IMMUNE ACTIVATION; VIRAL-INFECTION; ENZYME APOBEC3G; SEX-DIFFERENCES; INNATE;
D O I
10.3390/ijms24119624
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Toll-like receptors (TLRs) are evolutionarily conserved pattern recognition receptors that play important roles in the early detection of pathogen-associated molecular patterns and shaping innate and adaptive immune responses, which may influence the consequences of infection. Similarly to other viral infections, human immunodeficiency virus type 1 (HIV-1) also modulates the host TLR response; therefore, a proper understanding of the response induced by human HIV-1 or co-infection with hepatitis B virus (HBV) or hepatitis C virus (HCV), due to the common mode of transmission of these viruses, is essential for understanding HIV-1 pathogenesis during mono- or co-infection with HBV or HCV, as well as for HIV-1 cure strategies. In this review, we discuss the host TLR response during HIV-1 infection and the innate immune evasion mechanisms adopted by HIV-1 for infection establishment. We also examine changes in the host TLR response during HIV-1 co-infection with HBV or HCV; however, this type of study is extremely scarce. Moreover, we discuss studies investigating TLR agonists as latency-reverting agents and immune stimulators towards new strategies for curing HIV. This understanding will help develop a new strategy for curing HIV-1 mono-infection or co-infection with HBV or HCV.
引用
收藏
页数:20
相关论文
共 208 条
  • [111] Dual TLR2 and TLR7 agonists as HIV latency-reversing agents
    Macedo, Amanda B.
    Novis, Camille L.
    De Assis, Caroline M.
    Sorensen, Eric S.
    Moszczynski, Paula
    Huang, Szu-han
    Ren, Yanqin
    Spivak, Adam M.
    Jones, R. Brad
    Planelles, Vicente
    Basque, Alberto
    [J]. JCI INSIGHT, 2018, 3 (19):
  • [112] Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections
    Mandl, Judith N.
    Barry, Ashley P.
    Vanderford, Thomas H.
    Kozyr, Natalia
    Chavan, Rahul
    Mucking, Sara
    Barrat, Franck J.
    Coffman, Robert L.
    Staprans, Silvija I.
    Feinberg, Mark B.
    [J]. NATURE MEDICINE, 2008, 14 (10) : 1077 - 1087
  • [113] IL-15 regulates susceptibility of CD4+ T cells to HIV infection
    Manganaro, Lara
    Hong, Patrick
    Hernandez, Matthew M.
    Argyle, Dionne
    Mulder, Lubbertus C. F.
    Potla, Uma
    Diaz-Griffero, Felipe
    Lee, Benhur
    Fernandez-Sesma, Ana
    Simon, Viviana
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (41) : E9659 - E9667
  • [114] HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3
    Manganaro, Lara
    de Castro, Elisa
    Maestre, Ana M.
    Olivieri, Kevin
    Garcia-Sastre, Adolfo
    Fernandez-Sesma, Ana
    Simon, Viviana
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (19) : 9781 - 9790
  • [115] HIV-1 Vpu Neutralizes the Antiviral Factor Tetherin/BST-2 by Binding It and Directing Its Beta-TrCP2-Dependent Degradation
    Mangeat, Bastien
    Gers-Huber, Gustavo
    Lehmann, Martin
    Zufferey, Madeleine
    Luban, Jeremy
    Piguet, Vincent
    [J]. PLOS PATHOGENS, 2009, 5 (09)
  • [116] HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
    Marin, M
    Rose, KM
    Kozak, SL
    Kabat, D
    [J]. NATURE MEDICINE, 2003, 9 (11) : 1398 - 1403
  • [117] HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells
    Martinelli, Elena
    Cicala, Claudia
    Van Ryk, Donald
    Goode, Diana J.
    Macleod, Katilyn
    Arthos, James
    Fauci, Anthony S.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (09) : 3396 - 3401
  • [118] The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies
    Martinsen, Janne Tegder
    Gunst, Jesper Damsgaard
    Hojen, Jesper Falkesgaard
    Tolstrup, Martin
    Sogaard, Ole Schmeltz
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [119] Hitting the right spot on CXCR4
    McHugh, Jessica
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2019, 15 (09) : 514 - 514
  • [120] Sensing of HIV-1 by TLR8 activates human T cells and reverses latency
    Meas, Hany Zekaria
    Haug, Markus
    Beckwith, Marianne Sandvold
    Louet, Claire
    Ryan, Liv
    Hu, Zhenyi
    Landskron, Johannes
    Nordbo, Svein Arne
    Tasken, Kjetil
    Yin, Hang
    Damas, Jan Kristian
    Flo, Trude Helen
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)